OVID Financial Statements

Balance sheet, income statement, cash flow, and dividends for Ovid Therapeutics Inc (OVID).


$66.30M Market Cap.

As of 03/11/2025 5:00 PM ET (MRY) • Disclaimer

OVID Market Cap. (MRY)


OVID Shares Outstanding (MRY)


OVID Assets (MRY)


Total Assets

$92.17M

Total Liabilities

$23.94M

Total Investments

$47.75M

OVID Income (MRY)


Revenue

$566.00K

Net Income

-$26.43M

Operating Expense

$62.45M

OVID Cash Flow (MRY)


CF Operations

-$55.96M

CF Investing

$54.59M

CF Financing

$622.00K

OVID Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

OVID Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$92,167,000 (-36.01%)

$144,026,783 (-7.24%)

$155,265,814 (-20.19%)

$194,544,757 (156.23%)

Assets Current

$55,940,000 (-48.96%)

$109,597,707 (-16.58%)

$131,380,691 (-31.03%)

$190,479,129 (154.50%)

Assets Non-Current

$36,227,000 (5.22%)

$34,429,076 (44.14%)

$23,885,123 (487.49%)

$4,065,628 (275.64%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$68,226,000 (-22.29%)

$87,796,887 (-33.62%)

$132,272,564 (-26.41%)

$179,746,436 (311.96%)

Property Plant & Equipment Net

$13,230,000 (-9.77%)

$14,663,129 (-8.76%)

$16,070,632 (6520.05%)

$242,757 (79.00%)

Cash & Equivalents

$28,232,000 (-2.56%)

$28,972,270 (-38.09%)

$46,798,599 (-75.33%)

$189,728,285 (163.39%)

Accumulated Other Comprehensive Income

-$35,000 (-5085.75%)

$702 (101.66%)

-$42,187 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$47,748,000 (-50.48%)

$96,417,478 (7.42%)

$89,756,112 (5399.79%)

$1,631,992 (0%)

Investments Current

$26,774,000 (-66.02%)

$78,791,858 (-6.35%)

$84,133,565 (0%)

$0 (0%)

Investments Non-Current

$20,974,000 (19.00%)

$17,625,620 (213.48%)

$5,622,547 (244.52%)

$1,631,992 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$3,191,000 (-13.83%)

$3,702,936 (89.61%)

$1,952,910 (-72.60%)

$7,127,046 (-9.54%)

Accumulated Retained Earnings (Deficit)

-$304,299,000 (-9.51%)

-$277,865,501 (-23.21%)

-$225,526,542 (-31.61%)

-$171,357,513 (41.75%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$14,755,000 (-67.93%)

$46,001,725 (178.20%)

$16,535,671 (0%)

$0 (0%)

Debt Current

$1,336,000 (7.21%)

$1,246,119 (133.38%)

$533,946 (0%)

$0 (0%)

Debt Non-Current

$13,419,000 (-70.02%)

$44,755,606 (179.69%)

$16,001,725 (0%)

$0 (0%)

Total Liabilities

$23,941,000 (-57.42%)

$56,229,896 (144.55%)

$22,993,250 (55.38%)

$14,798,321 (-54.18%)

Liabilities Current

$10,522,000 (-8.30%)

$11,474,290 (64.12%)

$6,991,525 (-52.75%)

$14,798,321 (-32.93%)

Liabilities Non-Current

$13,419,000 (-70.02%)

$44,755,606 (179.69%)

$16,001,725 (0%)

$0 (0%)

OVID Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$566,000 (44.50%)

$391,695 (-73.93%)

$1,502,748 (-99.28%)

$208,382,779 (1551.57%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$25,684,000 (-17.38%)

$31,085,274 (-4.15%)

$32,432,510 (-12.90%)

$37,234,104 (21.56%)

Research & Development Expense

$36,767,000 (28.61%)

$28,587,884 (16.12%)

$24,618,399 (-47.55%)

$46,939,583 (-25.98%)

Operating Expenses

$62,451,000 (4.66%)

$59,673,158 (4.60%)

$57,050,909 (-32.22%)

$84,173,687 (-10.50%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$1,328,818 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$26,433,000 (49.50%)

-$52,338,959 (3.38%)

-$54,169,029 (-144.10%)

$122,834,584 (251.58%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$26,433,000 (49.50%)

-$52,338,959 (3.38%)

-$54,169,029 (-144.10%)

$122,834,584 (251.58%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$26,433,000 (49.50%)

-$52,338,959 (3.38%)

-$54,169,029 (-144.10%)

$122,834,584 (251.58%)

Weighted Average Shares

$70,905,422 (0.46%)

$70,580,604 (0.22%)

$70,424,819 (4.36%)

$67,479,403 (15.45%)

Weighted Average Shares Diluted

$70,905,422 (0.46%)

$70,580,604 (0.22%)

$70,424,819 (3.46%)

$68,067,992 (16.45%)

Earning Before Interest & Taxes (EBIT)

-$26,433,000 (49.50%)

-$52,338,959 (3.38%)

-$54,169,029 (-143.63%)

$124,163,402 (253.22%)

Gross Profit

$566,000 (44.50%)

$391,695 (-73.93%)

$1,502,748 (-99.28%)

$208,382,779 (1551.57%)

Operating Income

-$61,885,000 (-4.39%)

-$59,281,463 (-6.72%)

-$55,548,161 (-144.72%)

$124,209,092 (252.53%)

OVID Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$54,594,000 (2215.55%)

-$2,580,605 (97.06%)

-$87,883,217 (-4725.04%)

-$1,821,400 (-105.26%)

Net Cash Flow from Financing

$622,000 (-97.96%)

$30,535,201 (16802.21%)

$180,658 (-80.02%)

$904,082 (-98.08%)

Net Cash Flow from Operations

-$55,956,000 (-22.23%)

-$45,780,925 (17.10%)

-$55,227,127 (-146.56%)

$118,611,673 (329.94%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$740,000 (95.85%)

-$17,826,329 (87.53%)

-$142,929,686 (-221.44%)

$117,694,355 (290.53%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$54,754,000 (2341.12%)

-$2,443,150 (97.17%)

-$86,464,441 (-5198.09%)

-$1,631,992 (-104.66%)

Capital Expenditure

-$71,000 (-76.14%)

-$40,308 (96.71%)

-$1,224,379 (-565.39%)

-$184,008 (-44.61%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$30,000,000 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$622,000 (16.22%)

$535,201 (196.25%)

$180,658 (-80.02%)

$904,082 (-98.08%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$6,276,000 (-13.85%)

$7,285,192 (11.11%)

$6,556,686 (29.72%)

$5,054,457 (-32.83%)

Depreciation Amortization & Accretion

$1,710,000 (7.10%)

$1,596,575 (15.56%)

$1,381,605 (482.76%)

$237,079 (-22.74%)

OVID Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

Profit Margin

-4670.10% (65.05%)

-13362.20% (-270.69%)

-3604.70% (-6220.03%)

58.90% (109.17%)

EBITDA Margin

-4368.00% (66.28%)

-12954.60% (-268.79%)

-3512.70% (-5983.92%)

59.70% (109.33%)

Return on Average Equity (ROAE)

-33.90% (31.93%)

-49.80% (-36.07%)

-36.60% (-159.90%)

61.10% (135.67%)

Return on Average Assets (ROAA)

-23.80% (37.70%)

-38.20% (-21.27%)

-31.50% (-154.97%)

57.30% (148.56%)

Return on Sales (ROS)

-4670.10% (65.05%)

-13362.20% (-270.69%)

-3604.70% (-6148.15%)

59.60% (109.28%)

Return on Invested Capital (ROIC)

-27.60% (49.91%)

-55.10% (-0.73%)

-54.70% (96.46%)

-1545.40% (-183.38%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-2.52 (41.99%)

-4.35 (-80.09%)

-2.42 (-234.00%)

1.8 (208.48%)

Price to Sales Ratio (P/S)

116.97 (-79.84%)

580.22 (565.64%)

87.17 (8289.51%)

1.04 (-90.29%)

Price to Book Ratio (P/B)

0.97 (-62.50%)

2.59 (161.55%)

0.99 (-18.50%)

1.22 (-63.79%)

Debt to Equity Ratio (D/E)

0.35 (-45.16%)

0.64 (267.82%)

0.17 (112.20%)

0.08 (-88.92%)

Earnings Per Share (EPS)

-0.37 (50.00%)

-0.74 (3.90%)

-0.77 (-143.26%)

1.78 (228.06%)

Sales Per Share (SPS)

0.01 (33.33%)

0.01 (-71.43%)

0.02 (-99.32%)

3.09 (1329.63%)

Free Cash Flow Per Share (FCFPS)

-0.79 (-21.73%)

-0.65 (19.08%)

-0.8 (-145.70%)

1.75 (298.31%)

Book Value Per Share (BVPS)

0.96 (-22.67%)

1.24 (-33.76%)

1.88 (-29.50%)

2.66 (257.10%)

Tangible Assets Book Value Per Share (TABVPS)

1.3 (-36.31%)

2.04 (-7.44%)

2.21 (-23.52%)

2.88 (121.94%)

Enterprise Value Over EBIT (EV/EBIT)

-2 (50.00%)

-4 (-100.00%)

-2 (0%)

0 (0%)

Enterprise Value Over EBITDA (EV/EBITDA)

-2.65 (27.26%)

-3.64 (-120.23%)

-1.65 (-1322.96%)

0.14 (118.27%)

Asset Turnover

0.01 (66.67%)

0 (-66.67%)

0.01 (-99.08%)

0.97 (428.80%)

Current Ratio

5.32 (-44.35%)

9.55 (-49.17%)

18.79 (45.98%)

12.87 (279.48%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$56,027,000 (-22.27%)

-$45,821,233 (18.83%)

-$56,451,506 (-147.67%)

$118,427,665 (329.02%)

Enterprise Value (EV)

$65,400,912 (-64.56%)

$184,521,796 (111.78%)

$87,129,800 (418.74%)

$16,796,347 (-71.85%)

Earnings Before Tax (EBT)

-$26,433,000 (49.50%)

-$52,338,959 (3.38%)

-$54,169,029 (-143.63%)

$124,163,402 (253.22%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$24,723,000 (51.28%)

-$50,742,384 (3.87%)

-$52,787,424 (-142.43%)

$124,400,481 (254.10%)

Invested Capital

$68,168,000 (-54.43%)

$149,581,948 (26.75%)

$118,011,361 (1282.26%)

-$9,981,849 (45.07%)

Working Capital

$45,418,000 (-53.71%)

$98,123,417 (-21.12%)

$124,389,166 (-29.20%)

$175,680,808 (232.85%)

Tangible Asset Value

$92,167,000 (-36.01%)

$144,026,783 (-7.24%)

$155,265,814 (-20.19%)

$194,544,757 (156.23%)

Market Capitalization

$66,301,912 (-70.87%)

$227,591,374 (73.64%)

$131,068,406 (-40.04%)

$218,575,914 (49.16%)

Average Equity

$77,924,500 (-25.92%)

$105,183,799 (-28.87%)

$147,866,766 (-26.49%)

$201,146,912 (325.25%)

Average Assets

$111,131,750 (-18.98%)

$137,163,060 (-20.34%)

$172,180,901 (-19.64%)

$214,271,568 (212.12%)

Invested Capital Average

$95,676,750 (0.74%)

$94,978,159 (-4.07%)

$99,007,078 (1332.28%)

-$8,034,482 (-83.78%)

Shares

71,009,866 (0.47%)

70,680,551 (0.30%)

70,466,885 (3.49%)

68,092,185 (7.34%)